Pulmonary arterial hypertension trials put to the test: Using the fragility index to assess trials robustness

Randomized clinical trials (RCTs) are considered the gold standard of evidence-based medicine due to their statistical reliability and reduced risk of bias.1 In RCTs, the null hypothesis is rejected if the P-value is less than 0.05, indicating statistical significance. However, P-values alone may not accurately reflect the robustness of the RCT results.2
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research